Pain Management

The FDA has accepted Allergan's resubmission to approve the use of onabotulinumtoxinA (Botox) for lower limb spasticity in adults.

A pharmacist's perspective of OxyContin's approval for use in patients ages 11 to 16.

The FDA has expanded the use of the powerful painkiller oxycodone (OxyContin) for children as young as 11.

Pharmacists can have a positive impact by identifying and helping patients in pain.

Pain is associated with a variety of injuries and diseases, and is often the disease itself.

The low back, also known as the lumbosacral region, is a complex structure of interconnected and overlapping tendons, ligaments, muscles, nerves, joints, and discs.

The Centers for Disease Control and Prevention estimates that about 2% of the population is affected by fibromyalgia.

Migraines are usually unilateral in nature, with throbbing associated with them and an aura prior to onset, which alerts patients to the migraine.

Pain is a common complaint for which patients elect to use one of the various nonprescription analgesics currently on the market.

The recent explosion in deaths from opioids seems to be different from any previous observations.

Pharmacists can play pivotal roles in pain management, such as counseling patients on properly selecting and using analgesics.

Prescriptions for opioids from the emergency room may be deescalated.

Is there a need to strengthen the labeling of topical NSAIDs that clearly lack systemic therapeutic or toxic levels?

Pharmacists can help minimize risk for patients using pain medications.

Counseling family members about hospice medications requires compassion and empathy.

The FDA approved a 2.9-mg/0.71-mg dosage strength of Orexo's sublingual buprenorphine/naloxone (Zubsolv).

The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.

Chronic pain patients using prescription opioids in conjunction with medical marijuana are not at increased risk for substance abuse.

Regular trips to the emergency department could be a red flag for deadly prescription drug overdose.

Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.

Deaths related to oxycodone overdose dropped 25% in Florida after the state adopted a Prescription Drug Monitoring Program to track controlled substance dispensing.

The FDA today expanded the indication of Allergan's onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.

In addition to relieving pain, acetaminophen may cause patients to experience less intense emotional responses.

The FDA is warning pharmacists that pets are at risk of death when exposed to topical pain medications containing flurbiprofen.